Diffusion-Weighted MRI Monitoring of Embolic Brain Stroke for COVID-19 Patients

Hamed Taheri1, Reza Moghareabed2, Maryam Farghadani3

  • 1Nursing and Midwifery Department, Islamic Azad University of Isfahan (Khorasgan), Isfahan, Iran.

PubMed

Insights

COVID-19 patients experiencing embolic brain stroke often have lesions in the medial temporal lobe. Apparent diffusion coefficient (ADC) values in these COVID-19 stroke patients show no significant difference compared to other stroke patients.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Radiology

Background:

  • The COVID-19 pandemic has demonstrated widespread adverse effects on the human body.
  • Limited data exists on the specific impacts of COVID-19 on embolic brain stroke.

Purpose of the Study:

  • To investigate the characteristics of embolic brain stroke in COVID-19 patients.
  • To analyze diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) values in these patients.

Main Methods:

  • Included 52 COVID-19 patients diagnosed with embolic brain stroke.
  • Utilized MRIcro software to calculate ADC values from DWI scans.
  • Compared ADC values between COVID-19 patients and other embolic stroke patients.

Main Results:

  • Embolic strokes were predominantly located in the medial temporal lobe for both groups.
  • Mean ADC values in the central stroke region were significantly lower than in other brain areas for both COVID-19 and other patients.
  • Maximum ADC values in the edge regions were lower in COVID-19 patients compared to normal regions.

Conclusions:

  • Embolic brain stroke in COVID-19 patients frequently affects the medial temporal lobe.
  • ADC and relative ADC (rADC) values for embolic brain stroke in COVID-19 patients are comparable to those in other patient groups.
Abstract